The COVID-19 pandemic has starkly revealed the interconnected nature of global health security. The effects of a faltering health system can be felt well beyond sovereign borders. This means that preventing the spread of a future pandemic rests on the strengthening of the systems which deliver healthcare in geographies where patients are most vulnerable.
Providing a second manufacturer of quality-assured, child-friendly SPAQ provides both increased supply and greater security of supply for this important protective medicine.
The Swiss Malaria Group, of which MMV is a part, has remained committed to the success of malaria campaigns this year despite challenges posed by COVID-19. Although progress has been made, sustained commitment is needed to ensure efforts stay on track.
Participate in RBM Partnership To End Malaria's campaign by drawing the line against malaria. How can you get involved? Watch, download and share the films and animations and participate in the social media campaign. Visit the dedicated website to read the key messages and download the assets.